Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board approves EBD formulary changes; most specialty medical drugs excluded with appeals allowed
Summary
The Employee Benefits Division presented changes to the medical drug formulary, proposing exclusions for most medically administered specialty drugs to force case-by-case review; the board approved the recommendations and asked for periodic reporting on appeals.
The State Board of Finance approved medical drug formulary recommendations presented by the Employee Benefits Division (EBD). The EBD presenter said the month-to-month changes focus on quantity limits and adding prior-authorization requirements for certain drugs, and that most medically administered specialty drugs on the new list would be excluded initially to require review and an appeals path.
The presenter explained…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
